Zoom in on Dementia & Alzheimer's

Zoom in on Dementia & Alzheimer's is a monthly virtual discussion series with medical experts to keep you informed about the latest breakthroughs and findings in the field—from treatments and genetics to risk reduction, supplements, and more.

 

Each session will include a live Q&A where you can ask your questions directly of the experts. All sessions will be recorded and available to watch on demand.

Zoom in on Dementia & Alzheimer's - A free virtual discussion with medical experts.

Register for upcoming Zoom in on Dementia & Alzheimer's programs

Headshot of John Hardy, PhD

Is Alzheimer's Hereditary? Genetics and Dementia

June 22, 2023 - 1 pm ET / 10 am PT

Featured Expert: Professor Sir John Hardy PhD MD(Hons) DSc AEu FMedSci FRS
Chair of Molecular Biology of Neurological Disease, University College London Queen Square Institute of Neurology

Learn about the role that genes play in the risk of developing the early- and late-onset forms of Alzheimer’s disease. Dr. John Hardy, chair of molecular biology of neurological disease at University College London Institute of Neurology, and host Nancy Lynn discuss the impact of family history on Alzheimer’s disease.

Image/s courtesy of UCL QS IoN Medical Illustration Copyright 2022

Register Now

Previous Episodes

Malú Gámez Tansey, PhD
May 18, 2023

Bruce Willis Has Frontotemporal Dementia: What Are the Symptoms of FTD?

Learn about frontotemporal dementia (FTD), a form of dementia, and how it differs from Alzheimer’s disease. Dr. Malú Gámez Tansey, professor of neuroscience and neurology at the University of Florida, and host Nancy Lynn discuss the signs, symptoms, and stages of FTD.

 

Watch Now
Dr. Sharon Cohen
April 20, 2023

The New Alzheimer’s Drug: What is Leqembi?

Learn about Leqembi, a new anti-amyloid treatment for Alzheimer's disease that received conditional approval from the FDA in January 2023. Dr. Sharon Cohen, neurologist and medical director at Toronto Memory Program, and host Nancy Lynn discuss the drug's benefits, availability, potential side effects, cost, and more, as well as other drugs in development for Alzheimer's.

 

Watch now

This program is supported in part by educational grants from:

Eli Lilly logo Genentech logo

BrightFocus Foundation is dedicated to reaching millions of people worldwide through its public outreach and education efforts around brain and eye health.